CanSino Biologics Inc (CASBF)
2.10
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
CanSino Biologics Profit Margin (Quarterly): -148.8% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -148.8% |
| December 31, 2023 | -293.5% |
| September 30, 2023 | -92.92% |
| June 30, 2023 |
| Date | Value |
|---|---|
| March 31, 2023 | -138.8% |
| December 31, 2022 | -134.4% |
| September 30, 2022 | -627.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-627.1%
Minimum
Sep 2022
-92.92%
Maximum
Sep 2023
-239.3%
Average
-143.8%
Median
Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -279.5% |
| Zai Lab Ltd | -61.36% |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -25.77% |
| Return on Assets | -16.38% |
| Return on Invested Capital | -19.92% |
| Gross Profit Margin (Quarterly) | 59.55% |
| Operating Margin (Quarterly) | -92.51% |
| Return on Net Operating Assets | -28.68% |